| Gene Symbol | INHBB |
| Entrez ID | 3625 |
| Uniprot ID | P09529 |
| Description | inhibin beta B |
| Chromosomal Location | chr2: 120,346,143-120,351,808 |
| Ontology | GO ID | GO Term | Definition | Evidence |
|---|---|---|---|---|
|
BP |
GO:0001541 |
ovarian follicle development |
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure. |
NAS |
|
BP |
GO:0006952 |
defense response |
Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack. |
TAS |
|
BP |
GO:0009267 |
cellular response to starvation |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment. |
ISS |
|
BP |
GO:0009612 |
response to mechanical stimulus |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
IDA |
|
BP |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation |
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. |
IBA |
|
BP |
GO:0030154 |
cell differentiation |
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. |
NAS |
|
BP |
GO:0032869 |
cellular response to insulin stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms. |
ISS |
|
BP |
GO:0032924 |
activin receptor signaling pathway |
A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
IDA |
|
BP |
GO:0040007 |
growth |
The increase in size or mass of an entire organism, a part of an organism or a cell. |
IEA |
|
BP |
GO:0042981 |
regulation of apoptotic process |
Any process that modulates the occurrence or rate of cell death by apoptotic process. |
IBA |
|
BP |
GO:0043408 |
regulation of MAPK cascade |
Any process that modulates the frequency, rate or extent of signal transduction mediated by the MAP kinase (MAPK) cascade. |
IBA |
|
BP |
GO:0044320 |
cellular response to leptin stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leptin stimulus. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body. It plays a key role in regulating energy intake and energy expenditure, including appetite and metabolism. |
IEA |
|
BP |
GO:0045444 |
fat cell differentiation |
The process in which a relatively unspecialized cell acquires specialized features of an adipocyte, an animal connective tissue cell specialized for the synthesis and storage of fat. |
ISS |
|
BP |
GO:0046676 |
negative regulation of insulin secretion |
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of insulin. |
ISS |
|
BP |
GO:0046881 |
positive regulation of follicle-stimulating hormone secretion |
Any process that activates or increases the frequency, rate or extent of the regulated release of follicle-stimulating hormone. |
IPI |
|
BP |
GO:0046882 |
negative regulation of follicle-stimulating hormone secretion |
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of follicle-stimulating hormone. |
IPI |
|
BP |
GO:0048178 |
negative regulation of hepatocyte growth factor biosynthetic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of hepatocyte growth factor. |
IDA |
|
BP |
GO:0048468 |
cell development |
The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate. |
IBA |
|
BP |
GO:0048599 |
oocyte development |
The process whose specific outcome is the progression of an oocyte over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell. |
IEA |
|
BP |
GO:0060279 |
positive regulation of ovulation |
Any process that activates or increases the frequency, rate or extent of ovulation, the release of a mature ovum/oocyte from an ovary. |
ISS |
|
BP |
GO:0060395 |
SMAD protein signal transduction |
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell. |
IBA |
|
BP |
GO:2001235 |
positive regulation of apoptotic signaling pathway |
Any process that activates or increases the frequency, rate or extent of apoptotic signaling pathway. |
IEA |
|
CC |
GO:0005576 |
extracellular region |
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
TAS |
|
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
IBA |
|
CC |
GO:0048471 |
perinuclear region of cytoplasm |
Cytoplasm situated near, or occurring around, the nucleus. |
IDA |
|
CC |
GO:0071944 |
cell periphery |
The part of a cell encompassing the cell cortex, the plasma membrane, and any external encapsulating structures. |
IEA |
|
MF |
GO:0005125 |
cytokine activity |
Functions to control the survival, growth, differentiation and effector function of tissues and cells. |
TAS |
|
MF |
GO:0005160 |
transforming growth factor beta receptor binding |
Interacting selectively and non-covalently with the transforming growth factor beta receptor. |
IBA |
|
MF |
GO:0005179 |
hormone activity |
The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process. |
TAS |
|
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
|
MF |
GO:0008083 |
growth factor activity |
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
IEA |
|
MF |
GO:0042803 |
protein homodimerization activity |
Interacting selectively and non-covalently with an identical protein to form a homodimer. |
IPI |
|
MF |
GO:0046789 |
host cell surface receptor binding |
Interacting selectively and non-covalently with a receptor on the host cell surface. |
TAS |
| Domain ID | Description |
|---|---|
|
IPR000381 |
Inhibin, beta B subunit |
|
IPR001111 |
TGF-beta, propeptide |
|
IPR001839 |
Transforming growth factor-beta, C-terminal |
|
IPR015615 |
Transforming growth factor-beta-related |
|
IPR017948 |
Transforming growth factor beta, conserved site |
|
IPR029034 |
Cystine-knot cytokine |
| Pathway ID | Pathway Term | Pathway Source |
|---|---|---|
|
hsa04060 |
Cytokine-cytokine receptor interaction |
KEGG |
|
hsa04350 |
TGF-beta signaling pathway |
KEGG |
|
hsa04550 |
Signaling pathways regulating pluripotency of stem cells |
KEGG |
|
WP2324 |
AGE/RAGE pathway |
WikiPathways |
|
WP3927 |
BMP Signaling Pathway in Eyelid Development |
WikiPathways |
| Database Name |
|---|
|
DisGeNET |
|
DGA |
| Pubmed ID | Author | Year | Title |
|---|---|---|---|
|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
|
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
| Gene Symbol | Entrez ID | Uniprot ID | Score |
|---|---|---|---|
|
TGFB1 |
7040 |
P01137 |
0.00 |
|
TGFB3 |
7043 |
P10600 |
0.00 |
|
ACVR1 |
90 |
Q04771 |
0.52 |
|
INHA |
3623 |
P05111 |
0.52 |
|
INHBA |
3624 |
P08476 |
0.52 |
|
INHBB |
3625 |
P09529 |
0.52 |
|
FNTA |
2339 |
P49354 |
0.63 |
|
ACVR2A |
92 |
P27037 |
0.83 |
|
FST |
10468 |
P19883 |
0.00 |
|
INHBC |
3626 |
P55103 |
0.52 |
|
IGSF1 |
3547 |
Q8N6C5 |
0.55 |
|
ACVR1C |
130399 |
Q8NER5 |
0.65 |
|
ACVR2B |
93 |
Q13705 |
0.73 |
|
ACVR1B |
91 |
P36896 |
0.84 |